Insider Transactions in Q1 2025 at Marinus Pharmaceuticals, Inc. (MRNS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Elan Ezickson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,300
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Timothy M Mayleben Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,300
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,077
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Marvin Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,101
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
55,570
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Seth H. Z. Fischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,300
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Christine Berni Silverstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,702
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
179,536
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,628
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 11
2025
|
Steven Pfanstiel CFO AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,470
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Elan Ezickson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,600
-78.9%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Timothy M Mayleben Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
13,957
-100.0%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Timothy M Mayleben Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,600
-66.67%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,186
-20.22%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Marvin Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,389
-43.15%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,155
-23.59%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Seth H. Z. Fischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,707
-84.67%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Christine Berni Silverstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,398
-66.65%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
125,064
-41.06%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,778
-27.86%
|
$0
$0.55 P/Share
|
|
Feb 07
2025
|
Steven Pfanstiel CFO AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,303
-21.69%
|
$0
$0.55 P/Share
|
|
Jan 21
2025
|
Marvin Johnson Director |
SELL
Open market or private sale
|
Direct |
1,610
-11.42%
|
$0
$0.54 P/Share
|
|
Jan 21
2025
|
Elan Ezickson Director |
SELL
Open market or private sale
|
Direct |
1,600
-12.8%
|
$0
$0.54 P/Share
|